Morning Light Bio: Donate 1.91 million yuan of lycopene softgels to 14 fixed-point hospitals in Hebei Province

March 9, Morninglight Bio announced that 11,328 bottles of lycopene softgels worth 1.91 million yuan were donated to 14 New Corona pneumonia fixed-point hospitals in Hebei Province, and to the health care workers in Hebei Province, where the fighting is on the front line. these 14 designated hospitals include Hebei Chest Hospital, Yancheng Infectious Diseases Hospital, Tangshan City Infectious Diseases Hospital, Zhangzhou City People's Hospital, Dingzhou City People's Hospital, Xinji City First Hospital and so on. it is understood that Morninglight Bio donated more than 3 million yuan of lycopene softgels to Hubei Province on March 2 and March 6. "Since March, we have rushed to make lycopene softgels, hoping to donate to Wuhan 10,000 first-line health care workers, Hebei Province fixed-point hospital 10,000 first-line health care workers," Lu Qingguo, chairman of the Chenguang Biotech Group, told reporters. it is learned that Morninglight Is a gem-listed enterprise focused on plant extraction and leading the world natural pigment industry, and is an important international supplier of natural plant extracts Morning Light Bio's products include natural colors, natural fragrance extracts and essential oils, natural nutrition and medicinal extracts, plant protein and oil, such as four categories of more than 80 varieties, of which natural pigment production and sales are firmly the first in the country, single-product capsaicin, capsaicin resin, ephagocin production sales are ranked first in the world. 's 2019 annual results report, disclosed by Chenguang Bio, showed total operating income of RMB3,267 million, up 6.63% YoY, total profit of RMB210 million, up 38.99% YoY, and net profit attributable to shareholders of listed companies of RMB193 million, up 33.14% YoY 0
1
0
1